A phase 2 study of neoadjuvant chemotherapy with gemcitabine, epirubicin and paclitaxel (Taxol)[GET] in locally advanced breast cancer

Trial Profile

A phase 2 study of neoadjuvant chemotherapy with gemcitabine, epirubicin and paclitaxel (Taxol)[GET] in locally advanced breast cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2008

At a glance

  • Drugs Epirubicin (Primary) ; Gemcitabine (Primary) ; Paclitaxel (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2008 Last checked against ClinicalTrials.gov record.
    • 11 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top